It’s bonkers.” Roche is not a newcomer to the sequencing space: the company bought Jonathan Rothberg’s 454 in 2007 for $140 million. 454 had just announced the completion of Jim Watson’s ...
MiSeq and 454 GS Junior launched by Life Technologies, Illumina and Roche, respectively. Compared to the high-throughput NGS platforms, these benchtop sequencers offer a lower data throughput ...
Roche has put forward a new approach to genetic analysis, which it describes as sequencing-by-expansion—a proprietary method that pulls apart the DNA molecule and amplifies the signal of each ...
After extension, the sequencing adaptors enable amplification ... We modified transposon ends to contain Roche/454-compatible tags (A and B). After the tagging and fragmenting reaction, we heat ...
Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer ...
Basel, 20 February 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) unveiled today its proprietary, breakthrough sequencing by expansion (SBX) technology, establishing a new category of next-generation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results